2-151603751-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001164507.2(NEB):​c.13081G>A​(p.Glu4361Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 151,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E4361E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0026 ( 0 hom., cov: 22)
Exomes 𝑓: 0.0035 ( 3 hom. )
Failed GnomAD Quality Control

Consequence

NEB
NM_001164507.2 missense

Scores

1
1
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: -0.851

Publications

3 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0210782).
BP6
Variant 2-151603751-C-T is Benign according to our data. Variant chr2-151603751-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 257730.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.13081G>A p.Glu4361Lys missense_variant Exon 86 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.13081G>A p.Glu4361Lys missense_variant Exon 86 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.13081G>A p.Glu4361Lys missense_variant Exon 86 of 182 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.13081G>A p.Glu4361Lys missense_variant Exon 86 of 182 5 NM_001164507.2 ENSP00000416578.2 P20929-3
NEBENST00000409198.5 linkc.11601+6058G>A intron_variant Intron 78 of 149 5 ENSP00000386259.1 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.00258
AC:
392
AN:
151676
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000948
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00189
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00442
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00206
AC:
326
AN:
157902
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.000604
Gnomad AMR exome
AF:
0.000809
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00217
Gnomad NFE exome
AF:
0.00320
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00355
AC:
4932
AN:
1389958
Hom.:
3
Cov.:
32
AF XY:
0.00354
AC XY:
2428
AN XY:
685614
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000735
AC:
23
AN:
31288
American (AMR)
AF:
0.000953
AC:
34
AN:
35662
Ashkenazi Jewish (ASJ)
AF:
0.0000794
AC:
2
AN:
25176
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35736
South Asian (SAS)
AF:
0.00297
AC:
234
AN:
78842
European-Finnish (FIN)
AF:
0.00269
AC:
133
AN:
49454
Middle Eastern (MID)
AF:
0.000246
AC:
1
AN:
4070
European-Non Finnish (NFE)
AF:
0.00407
AC:
4359
AN:
1071956
Other (OTH)
AF:
0.00253
AC:
146
AN:
57774
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.255
Heterozygous variant carriers
0
677
1353
2030
2706
3383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00258
AC:
392
AN:
151794
Hom.:
0
Cov.:
22
AF XY:
0.00219
AC XY:
163
AN XY:
74286
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000945
AC:
39
AN:
41266
American (AMR)
AF:
0.000915
AC:
14
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4822
European-Finnish (FIN)
AF:
0.00189
AC:
20
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00442
AC:
300
AN:
67812
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.284
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00280
Hom.:
0
ExAC
AF:
0.00405
AC:
106

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Dec 22, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: BP4, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nemaline myopathy 2 Uncertain:2
Dec 15, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
17
DANN
Benign
0.92
DEOGEN2
Benign
0.015
.;T;.;.;.
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.90
D;T;D;.;.
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.021
T;T;T;T;T
MetaSVM
Benign
-0.83
T
PhyloP100
-0.85
PROVEAN
Benign
-0.61
N;.;N;.;.
REVEL
Benign
0.095
Sift
Benign
0.13
T;.;T;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;D
Vest4
0.32
MVP
0.62
MPC
0.29
ClinPred
0.028
T
GERP RS
0.82
gMVP
0.016
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202017360; hg19: chr2-152460265; COSMIC: COSV51170428; API